nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—colon cancer—breast cancer	0.212	1	CtDrD
Fluorouracil—Nucleic Acid Synthesis Inhibitors—Capecitabine—breast cancer	0.162	0.5	CiPCiCtD
Fluorouracil—Nucleic Acid Synthesis Inhibitors—Gemcitabine—breast cancer	0.162	0.5	CiPCiCtD
Fluorouracil—UMPS—breast cancer	0.0853	0.475	CbGaD
Fluorouracil—DPYD—Capecitabine—breast cancer	0.04	0.235	CbGbCtD
Fluorouracil—DPYD—breast cancer	0.0381	0.212	CbGaD
Fluorouracil—TYMP—Capecitabine—breast cancer	0.0266	0.156	CbGbCtD
Fluorouracil—TYMS—breast cancer	0.0211	0.117	CbGaD
Fluorouracil—MTHFR—breast cancer	0.0167	0.0933	CbGaD
Fluorouracil—TYMS—Capecitabine—breast cancer	0.0141	0.083	CbGbCtD
Fluorouracil—ABCG2—breast cancer	0.0128	0.0714	CbGaD
Fluorouracil—SLC29A1—Gemcitabine—breast cancer	0.0106	0.0621	CbGbCtD
Fluorouracil—TYMS—Gemcitabine—breast cancer	0.0098	0.0575	CbGbCtD
Fluorouracil—CYP2A6—Letrozole—breast cancer	0.00879	0.0516	CbGbCtD
Fluorouracil—ALB—breast cancer	0.00559	0.0311	CbGaD
Fluorouracil—MTHFR—Methotrexate—breast cancer	0.00543	0.0319	CbGbCtD
Fluorouracil—TYMS—Methotrexate—breast cancer	0.00462	0.0271	CbGbCtD
Fluorouracil—CYP1A2—Anastrozole—breast cancer	0.00299	0.0176	CbGbCtD
Fluorouracil—CYP1A2—Toremifene—breast cancer	0.00273	0.0161	CbGbCtD
Fluorouracil—CYP2C9—Anastrozole—breast cancer	0.00269	0.0158	CbGbCtD
Fluorouracil—CYP2A6—Tamoxifen—breast cancer	0.00262	0.0154	CbGbCtD
Fluorouracil—SLC22A7—Docetaxel—breast cancer	0.00259	0.0152	CbGbCtD
Fluorouracil—CYP2C8—Lapatinib—breast cancer	0.00258	0.0151	CbGbCtD
Fluorouracil—ABCC3—Doxorubicin—breast cancer	0.00247	0.0145	CbGbCtD
Fluorouracil—ABCG2—Tamoxifen—breast cancer	0.00242	0.0142	CbGbCtD
Fluorouracil—ABCC3—Methotrexate—breast cancer	0.0024	0.0141	CbGbCtD
Fluorouracil—ABCG2—Mitoxantrone—breast cancer	0.00236	0.0139	CbGbCtD
Fluorouracil—CYP2C9—Idarubicin—breast cancer	0.00204	0.012	CbGbCtD
Fluorouracil—CYP2C8—Raloxifene—breast cancer	0.00195	0.0115	CbGbCtD
Fluorouracil—ABCG2—Paclitaxel—breast cancer	0.00189	0.0111	CbGbCtD
Fluorouracil—SLC22A7—Methotrexate—breast cancer	0.00187	0.011	CbGbCtD
Fluorouracil—ABCG2—Irinotecan—breast cancer	0.00186	0.0109	CbGbCtD
Fluorouracil—ABCC4—Methotrexate—breast cancer	0.00183	0.0108	CbGbCtD
Fluorouracil—ABCG2—Carboplatin—breast cancer	0.00177	0.0104	CbGbCtD
Fluorouracil—ABCG2—Docetaxel—breast cancer	0.00136	0.00801	CbGbCtD
Fluorouracil—CYP2C8—Tamoxifen—breast cancer	0.00129	0.00758	CbGbCtD
Fluorouracil—ALB—Irinotecan—breast cancer	0.00128	0.00753	CbGbCtD
Fluorouracil—CYP2C9—Capecitabine—breast cancer	0.00112	0.00657	CbGbCtD
Fluorouracil—ABCG2—Doxorubicin—breast cancer	0.00102	0.00597	CbGbCtD
Fluorouracil—CYP2C8—Paclitaxel—breast cancer	0.001	0.0059	CbGbCtD
Fluorouracil—CYP1A2—Tamoxifen—breast cancer	0.000999	0.00587	CbGbCtD
Fluorouracil—ABCG2—Methotrexate—breast cancer	0.000985	0.00578	CbGbCtD
Fluorouracil—CYP2C9—Tamoxifen—breast cancer	0.0009	0.00529	CbGbCtD
Fluorouracil—CYP2C9—Paclitaxel—breast cancer	0.000701	0.00411	CbGbCtD
Fluorouracil—ALB—Methotrexate—breast cancer	0.000679	0.00399	CbGbCtD
Fluorouracil—DPYD—mammary gland—breast cancer	0.000593	0.0302	CbGeAlD
Fluorouracil—PPAT—nipple—breast cancer	0.000425	0.0216	CbGeAlD
Fluorouracil—UPP1—skin of body—breast cancer	0.000387	0.0197	CbGeAlD
Fluorouracil—UMPS—uterus—breast cancer	0.000367	0.0187	CbGeAlD
Fluorouracil—UPP1—endometrium—breast cancer	0.000365	0.0186	CbGeAlD
Fluorouracil—UMPS—adipose tissue—breast cancer	0.000358	0.0182	CbGeAlD
Fluorouracil—TYMP—mammary gland—breast cancer	0.000344	0.0175	CbGeAlD
Fluorouracil—UPP1—uterus—breast cancer	0.000336	0.0171	CbGeAlD
Fluorouracil—UPP1—pituitary gland—breast cancer	0.00033	0.0168	CbGeAlD
Fluorouracil—UMPS—female reproductive system—breast cancer	0.000329	0.0168	CbGeAlD
Fluorouracil—UPP1—adipose tissue—breast cancer	0.000329	0.0167	CbGeAlD
Fluorouracil—MTHFR—mammary gland—breast cancer	0.000323	0.0164	CbGeAlD
Fluorouracil—UMPS—adrenal gland—breast cancer	0.000322	0.0164	CbGeAlD
Fluorouracil—UMPS—bone marrow—breast cancer	0.000311	0.0158	CbGeAlD
Fluorouracil—UPP1—female reproductive system—breast cancer	0.000302	0.0154	CbGeAlD
Fluorouracil—UMPS—female gonad—breast cancer	0.0003	0.0153	CbGeAlD
Fluorouracil—UPP1—adrenal gland—breast cancer	0.000295	0.015	CbGeAlD
Fluorouracil—ABCC5—mammary gland—breast cancer	0.000288	0.0147	CbGeAlD
Fluorouracil—UPP1—bone marrow—breast cancer	0.000285	0.0145	CbGeAlD
Fluorouracil—TYMP—nipple—breast cancer	0.000284	0.0145	CbGeAlD
Fluorouracil—UMPS—endocrine gland—breast cancer	0.000279	0.0142	CbGeAlD
Fluorouracil—UPP1—female gonad—breast cancer	0.000275	0.014	CbGeAlD
Fluorouracil—DPYD—uterus—breast cancer	0.000273	0.0139	CbGeAlD
Fluorouracil—DPYD—adipose tissue—breast cancer	0.000267	0.0136	CbGeAlD
Fluorouracil—SLC29A1—mammary gland—breast cancer	0.000264	0.0135	CbGeAlD
Fluorouracil—PPAT—endometrium—breast cancer	0.000256	0.013	CbGeAlD
Fluorouracil—UPP1—endocrine gland—breast cancer	0.000256	0.013	CbGeAlD
Fluorouracil—DPYD—adrenal gland—breast cancer	0.000239	0.0122	CbGeAlD
Fluorouracil—PPAT—pituitary gland—breast cancer	0.000232	0.0118	CbGeAlD
Fluorouracil—DPYD—bone marrow—breast cancer	0.000232	0.0118	CbGeAlD
Fluorouracil—PPAT—adipose tissue—breast cancer	0.000231	0.0118	CbGeAlD
Fluorouracil—DPYD—female gonad—breast cancer	0.000223	0.0114	CbGeAlD
Fluorouracil—SLC29A1—nipple—breast cancer	0.000219	0.0111	CbGeAlD
Fluorouracil—PPAT—female reproductive system—breast cancer	0.000212	0.0108	CbGeAlD
Fluorouracil—PPAT—adrenal gland—breast cancer	0.000207	0.0105	CbGeAlD
Fluorouracil—ALB—mammary gland—breast cancer	0.000206	0.0105	CbGeAlD
Fluorouracil—PPAT—bone marrow—breast cancer	0.0002	0.0102	CbGeAlD
Fluorouracil—PPAT—female gonad—breast cancer	0.000193	0.00984	CbGeAlD
Fluorouracil—UMPS—lymph node—breast cancer	0.000193	0.00981	CbGeAlD
Fluorouracil—PPAT—endocrine gland—breast cancer	0.00018	0.00915	CbGeAlD
Fluorouracil—UPP1—lymph node—breast cancer	0.000177	0.009	CbGeAlD
Fluorouracil—TYMP—endometrium—breast cancer	0.000172	0.00874	CbGeAlD
Fluorouracil—TYMP—uterus—breast cancer	0.000158	0.00805	CbGeAlD
Fluorouracil—TYMS—skin of body—breast cancer	0.000156	0.00795	CbGeAlD
Fluorouracil—TYMP—pituitary gland—breast cancer	0.000155	0.0079	CbGeAlD
Fluorouracil—TYMP—adipose tissue—breast cancer	0.000155	0.00787	CbGeAlD
Fluorouracil—TYMS—endometrium—breast cancer	0.000147	0.00749	CbGeAlD
Fluorouracil—MTHFR—adipose tissue—breast cancer	0.000145	0.0074	CbGeAlD
Fluorouracil—CYP2C8—mammary gland—breast cancer	0.000145	0.00738	CbGeAlD
Fluorouracil—DPYD—lymph node—breast cancer	0.000144	0.00731	CbGeAlD
Fluorouracil—TYMP—female reproductive system—breast cancer	0.000142	0.00724	CbGeAlD
Fluorouracil—TYMP—adrenal gland—breast cancer	0.000139	0.00706	CbGeAlD
Fluorouracil—TYMP—bone marrow—breast cancer	0.000134	0.00683	CbGeAlD
Fluorouracil—MTHFR—female reproductive system—breast cancer	0.000134	0.0068	CbGeAlD
Fluorouracil—TYMS—adipose tissue—breast cancer	0.000133	0.00675	CbGeAlD
Fluorouracil—SLC29A1—endometrium—breast cancer	0.000132	0.00672	CbGeAlD
Fluorouracil—MTHFR—adrenal gland—breast cancer	0.00013	0.00664	CbGeAlD
Fluorouracil—ABCC5—pituitary gland—breast cancer	0.00013	0.00662	CbGeAlD
Fluorouracil—ABCC5—adipose tissue—breast cancer	0.00013	0.0066	CbGeAlD
Fluorouracil—TYMP—female gonad—breast cancer	0.000129	0.00658	CbGeAlD
Fluorouracil—CYP2C9—mammary gland—breast cancer	0.000129	0.00655	CbGeAlD
Fluorouracil—PPAT—lymph node—breast cancer	0.000124	0.00632	CbGeAlD
Fluorouracil—TYMS—female reproductive system—breast cancer	0.000122	0.00621	CbGeAlD
Fluorouracil—SLC29A1—uterus—breast cancer	0.000122	0.00619	CbGeAlD
Fluorouracil—MTHFR—female gonad—breast cancer	0.000122	0.00619	CbGeAlD
Fluorouracil—TYMP—endocrine gland—breast cancer	0.00012	0.00612	CbGeAlD
Fluorouracil—SLC22A7—endocrine gland—breast cancer	0.00012	0.00611	CbGeAlD
Fluorouracil—SLC29A1—pituitary gland—breast cancer	0.000119	0.00608	CbGeAlD
Fluorouracil—TYMS—adrenal gland—breast cancer	0.000119	0.00606	CbGeAlD
Fluorouracil—SLC29A1—adipose tissue—breast cancer	0.000119	0.00606	CbGeAlD
Fluorouracil—ABCC5—adrenal gland—breast cancer	0.000116	0.00592	CbGeAlD
Fluorouracil—CYP2A6—adipose tissue—breast cancer	0.000116	0.00591	CbGeAlD
Fluorouracil—TYMS—bone marrow—breast cancer	0.000115	0.00586	CbGeAlD
Fluorouracil—MTHFR—endocrine gland—breast cancer	0.000113	0.00576	CbGeAlD
Fluorouracil—ABCC5—bone marrow—breast cancer	0.000112	0.00572	CbGeAlD
Fluorouracil—UMPS—Epirubicin—Idarubicin—breast cancer	0.000112	0.115	CbGdCrCtD
Fluorouracil—UMPS—Daunorubicin—Idarubicin—breast cancer	0.000112	0.115	CbGdCrCtD
Fluorouracil—UMPS—Doxorubicin—Idarubicin—breast cancer	0.000112	0.115	CbGdCrCtD
Fluorouracil—CYP1A2—nipple—breast cancer	0.000112	0.00571	CbGeAlD
Fluorouracil—TYMS—female gonad—breast cancer	0.000111	0.00565	CbGeAlD
Fluorouracil—SLC29A1—female reproductive system—breast cancer	0.000109	0.00557	CbGeAlD
Fluorouracil—ABCC3—adipose tissue—breast cancer	0.000109	0.00554	CbGeAlD
Fluorouracil—ABCC5—female gonad—breast cancer	0.000108	0.00552	CbGeAlD
Fluorouracil—SLC29A1—adrenal gland—breast cancer	0.000107	0.00543	CbGeAlD
Fluorouracil—SLC29A1—bone marrow—breast cancer	0.000103	0.00526	CbGeAlD
Fluorouracil—TYMS—endocrine gland—breast cancer	0.000103	0.00525	CbGeAlD
Fluorouracil—ABCC3—female reproductive system—breast cancer	0.0001	0.00509	CbGeAlD
Fluorouracil—SLC29A1—female gonad—breast cancer	9.95e-05	0.00507	CbGeAlD
Fluorouracil—ABCC3—adrenal gland—breast cancer	9.76e-05	0.00497	CbGeAlD
Fluorouracil—SLC29A1—endocrine gland—breast cancer	9.25e-05	0.00471	CbGeAlD
Fluorouracil—ABCC4—uterus—breast cancer	9.18e-05	0.00468	CbGeAlD
Fluorouracil—ABCC3—female gonad—breast cancer	9.1e-05	0.00463	CbGeAlD
Fluorouracil—ABCC4—adipose tissue—breast cancer	8.98e-05	0.00457	CbGeAlD
Fluorouracil—ABCC3—endocrine gland—breast cancer	8.46e-05	0.00431	CbGeAlD
Fluorouracil—ALB—adrenal gland—breast cancer	8.32e-05	0.00424	CbGeAlD
Fluorouracil—TYMP—lymph node—breast cancer	8.31e-05	0.00423	CbGeAlD
Fluorouracil—ABCC4—female reproductive system—breast cancer	8.26e-05	0.0042	CbGeAlD
Fluorouracil—ABCC4—adrenal gland—breast cancer	8.06e-05	0.0041	CbGeAlD
Fluorouracil—MTHFR—lymph node—breast cancer	7.82e-05	0.00398	CbGeAlD
Fluorouracil—ABCC4—bone marrow—breast cancer	7.79e-05	0.00397	CbGeAlD
Fluorouracil—TYMS—Docetaxel—Paclitaxel—breast cancer	7.71e-05	0.079	CbGdCrCtD
Fluorouracil—TYMS—Gefitinib—Lapatinib—breast cancer	7.56e-05	0.0775	CbGdCrCtD
Fluorouracil—ABCC4—female gonad—breast cancer	7.51e-05	0.00382	CbGeAlD
Fluorouracil—CYP2C8—endometrium—breast cancer	7.24e-05	0.00368	CbGeAlD
Fluorouracil—TYMS—lymph node—breast cancer	7.13e-05	0.00363	CbGeAlD
Fluorouracil—ABCG2—endometrium—breast cancer	7.04e-05	0.00358	CbGeAlD
Fluorouracil—ABCC4—endocrine gland—breast cancer	6.99e-05	0.00356	CbGeAlD
Fluorouracil—ABCC5—lymph node—breast cancer	6.97e-05	0.00355	CbGeAlD
Fluorouracil—CYP2C8—pituitary gland—breast cancer	6.55e-05	0.00333	CbGeAlD
Fluorouracil—ABCG2—uterus—breast cancer	6.48e-05	0.0033	CbGeAlD
Fluorouracil—SLC29A1—lymph node—breast cancer	6.4e-05	0.00326	CbGeAlD
Fluorouracil—ABCG2—pituitary gland—breast cancer	6.37e-05	0.00324	CbGeAlD
Fluorouracil—ABCG2—adipose tissue—breast cancer	6.34e-05	0.00323	CbGeAlD
Fluorouracil—CYP2C8—female reproductive system—breast cancer	5.99e-05	0.00305	CbGeAlD
Fluorouracil—ABCC3—lymph node—breast cancer	5.85e-05	0.00298	CbGeAlD
Fluorouracil—ABCG2—adrenal gland—breast cancer	5.69e-05	0.0029	CbGeAlD
Fluorouracil—ABCG2—bone marrow—breast cancer	5.5e-05	0.0028	CbGeAlD
Fluorouracil—CYP2C9—female reproductive system—breast cancer	5.32e-05	0.00271	CbGeAlD
Fluorouracil—ABCG2—female gonad—breast cancer	5.3e-05	0.0027	CbGeAlD
Fluorouracil—UMPS—Doxorubicin—Epirubicin—breast cancer	5.15e-05	0.0528	CbGdCrCtD
Fluorouracil—UMPS—Idarubicin—Epirubicin—breast cancer	5.15e-05	0.0528	CbGdCrCtD
Fluorouracil—UMPS—Daunorubicin—Epirubicin—breast cancer	5.15e-05	0.0528	CbGdCrCtD
Fluorouracil—CYP2C8—endocrine gland—breast cancer	5.07e-05	0.00258	CbGeAlD
Fluorouracil—ALB—lymph node—breast cancer	4.99e-05	0.00254	CbGeAlD
Fluorouracil—ABCC4—lymph node—breast cancer	4.83e-05	0.00246	CbGeAlD
Fluorouracil—UMPS—Daunorubicin—Doxorubicin—breast cancer	4.77e-05	0.0489	CbGdCrCtD
Fluorouracil—UMPS—Epirubicin—Doxorubicin—breast cancer	4.77e-05	0.0489	CbGdCrCtD
Fluorouracil—UMPS—Idarubicin—Doxorubicin—breast cancer	4.77e-05	0.0489	CbGdCrCtD
Fluorouracil—CYP1A2—endocrine gland—breast cancer	4.75e-05	0.00242	CbGeAlD
Fluorouracil—CYP2C9—endocrine gland—breast cancer	4.51e-05	0.00229	CbGeAlD
Fluorouracil—TYMS—Paclitaxel—Docetaxel—breast cancer	3.85e-05	0.0394	CbGdCrCtD
Fluorouracil—ABCG2—lymph node—breast cancer	3.41e-05	0.00174	CbGeAlD
Fluorouracil—TYMS—Vincristine—Vinorelbine—breast cancer	2.65e-05	0.0271	CbGdCrCtD
Fluorouracil—TYMS—Vinorelbine—Vinblastine—breast cancer	2.47e-05	0.0254	CbGdCrCtD
Fluorouracil—TYMS—Vinblastine—Vinorelbine—breast cancer	2.13e-05	0.0218	CbGdCrCtD
Fluorouracil—TYMS—Vincristine—Vinblastine—breast cancer	2.11e-05	0.0217	CbGdCrCtD
Fluorouracil—TYMS—Clobetasol propionate—Fluoxymesterone—breast cancer	1.7e-05	0.0175	CbGdCrCtD
Fluorouracil—TYMS—Triamcinolone—Fluoxymesterone—breast cancer	1.66e-05	0.0171	CbGdCrCtD
Fluorouracil—TYMS—Danazol—Fluoxymesterone—breast cancer	1.29e-05	0.0132	CbGdCrCtD
Fluorouracil—Chest pain—Docetaxel—breast cancer	1.05e-05	0.000212	CcSEcCtD
Fluorouracil—Myalgia—Docetaxel—breast cancer	1.05e-05	0.000212	CcSEcCtD
Fluorouracil—Pancytopenia—Doxorubicin—breast cancer	1.05e-05	0.000212	CcSEcCtD
Fluorouracil—Nausea—Vinorelbine—breast cancer	1.05e-05	0.000212	CcSEcCtD
Fluorouracil—Dyspepsia—Paclitaxel—breast cancer	1.05e-05	0.000211	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Epirubicin—breast cancer	1.05e-05	0.000211	CcSEcCtD
Fluorouracil—Stomatitis—Epirubicin—breast cancer	1.04e-05	0.00021	CcSEcCtD
Fluorouracil—Conjunctivitis—Epirubicin—breast cancer	1.04e-05	0.000209	CcSEcCtD
Fluorouracil—Urinary tract infection—Epirubicin—breast cancer	1.04e-05	0.000209	CcSEcCtD
Fluorouracil—Decreased appetite—Paclitaxel—breast cancer	1.03e-05	0.000209	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Doxorubicin—breast cancer	1.03e-05	0.000208	CcSEcCtD
Fluorouracil—Haemoglobin—Methotrexate—breast cancer	1.03e-05	0.000207	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Paclitaxel—breast cancer	1.03e-05	0.000207	CcSEcCtD
Fluorouracil—Haemorrhage—Methotrexate—breast cancer	1.02e-05	0.000206	CcSEcCtD
Fluorouracil—Myalgia—Capecitabine—breast cancer	1.02e-05	0.000206	CcSEcCtD
Fluorouracil—Chest pain—Capecitabine—breast cancer	1.02e-05	0.000206	CcSEcCtD
Fluorouracil—Pain—Paclitaxel—breast cancer	1.02e-05	0.000205	CcSEcCtD
Fluorouracil—Confusional state—Docetaxel—breast cancer	1.02e-05	0.000205	CcSEcCtD
Fluorouracil—Pharyngitis—Methotrexate—breast cancer	1.02e-05	0.000205	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Doxorubicin—breast cancer	1.01e-05	0.000204	CcSEcCtD
Fluorouracil—Oedema—Docetaxel—breast cancer	1.01e-05	0.000203	CcSEcCtD
Fluorouracil—Anaphylactic shock—Docetaxel—breast cancer	1.01e-05	0.000203	CcSEcCtD
Fluorouracil—Discomfort—Capecitabine—breast cancer	1.01e-05	0.000203	CcSEcCtD
Fluorouracil—Epistaxis—Epirubicin—breast cancer	1.01e-05	0.000203	CcSEcCtD
Fluorouracil—Pruritus—Gemcitabine—breast cancer	1.01e-05	0.000203	CcSEcCtD
Fluorouracil—Nausea—Thiotepa—breast cancer	1e-05	0.000202	CcSEcCtD
Fluorouracil—Infection—Docetaxel—breast cancer	1e-05	0.000202	CcSEcCtD
Fluorouracil—Sinusitis—Epirubicin—breast cancer	1e-05	0.000202	CcSEcCtD
Fluorouracil—Diarrhoea—Mitoxantrone—breast cancer	9.99e-06	0.000201	CcSEcCtD
Fluorouracil—Diarrhoea—Irinotecan—breast cancer	9.99e-06	0.000201	CcSEcCtD
Fluorouracil—TYMS—Azacitidine—Gemcitabine—breast cancer	9.97e-06	0.0102	CbGdCrCtD
Fluorouracil—Agranulocytosis—Epirubicin—breast cancer	9.96e-06	0.000201	CcSEcCtD
Fluorouracil—Pneumonia—Doxorubicin—breast cancer	9.93e-06	0.0002	CcSEcCtD
Fluorouracil—Nervous system disorder—Docetaxel—breast cancer	9.9e-06	0.0002	CcSEcCtD
Fluorouracil—Thrombocytopenia—Docetaxel—breast cancer	9.88e-06	0.000199	CcSEcCtD
Fluorouracil—Infestation—Doxorubicin—breast cancer	9.87e-06	0.000199	CcSEcCtD
Fluorouracil—Infestation NOS—Doxorubicin—breast cancer	9.87e-06	0.000199	CcSEcCtD
Fluorouracil—Confusional state—Capecitabine—breast cancer	9.85e-06	0.000199	CcSEcCtD
Fluorouracil—Tachycardia—Docetaxel—breast cancer	9.85e-06	0.000199	CcSEcCtD
Fluorouracil—Feeling abnormal—Paclitaxel—breast cancer	9.81e-06	0.000198	CcSEcCtD
Fluorouracil—Oedema—Capecitabine—breast cancer	9.77e-06	0.000197	CcSEcCtD
Fluorouracil—Diarrhoea—Gemcitabine—breast cancer	9.73e-06	0.000196	CcSEcCtD
Fluorouracil—Infection—Capecitabine—breast cancer	9.71e-06	0.000196	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Doxorubicin—breast cancer	9.68e-06	0.000195	CcSEcCtD
Fluorouracil—Dizziness—Irinotecan—breast cancer	9.65e-06	0.000195	CcSEcCtD
Fluorouracil—Haemoglobin—Epirubicin—breast cancer	9.63e-06	0.000194	CcSEcCtD
Fluorouracil—Stomatitis—Doxorubicin—breast cancer	9.62e-06	0.000194	CcSEcCtD
Fluorouracil—Anorexia—Docetaxel—breast cancer	9.62e-06	0.000194	CcSEcCtD
Fluorouracil—Rhinitis—Epirubicin—breast cancer	9.6e-06	0.000194	CcSEcCtD
Fluorouracil—Urinary tract infection—Doxorubicin—breast cancer	9.6e-06	0.000194	CcSEcCtD
Fluorouracil—Conjunctivitis—Doxorubicin—breast cancer	9.6e-06	0.000194	CcSEcCtD
Fluorouracil—Nervous system disorder—Capecitabine—breast cancer	9.58e-06	0.000193	CcSEcCtD
Fluorouracil—Haemorrhage—Epirubicin—breast cancer	9.58e-06	0.000193	CcSEcCtD
Fluorouracil—Thrombocytopenia—Capecitabine—breast cancer	9.57e-06	0.000193	CcSEcCtD
Fluorouracil—Tachycardia—Capecitabine—breast cancer	9.54e-06	0.000192	CcSEcCtD
Fluorouracil—Hypoaesthesia—Epirubicin—breast cancer	9.53e-06	0.000192	CcSEcCtD
Fluorouracil—Pharyngitis—Epirubicin—breast cancer	9.51e-06	0.000192	CcSEcCtD
Fluorouracil—Urticaria—Paclitaxel—breast cancer	9.46e-06	0.000191	CcSEcCtD
Fluorouracil—Hypotension—Docetaxel—breast cancer	9.43e-06	0.00019	CcSEcCtD
Fluorouracil—Body temperature increased—Paclitaxel—breast cancer	9.41e-06	0.00019	CcSEcCtD
Fluorouracil—Epistaxis—Doxorubicin—breast cancer	9.31e-06	0.000188	CcSEcCtD
Fluorouracil—Anorexia—Capecitabine—breast cancer	9.31e-06	0.000188	CcSEcCtD
Fluorouracil—Vomiting—Mitoxantrone—breast cancer	9.28e-06	0.000187	CcSEcCtD
Fluorouracil—Vomiting—Irinotecan—breast cancer	9.28e-06	0.000187	CcSEcCtD
Fluorouracil—Sinusitis—Doxorubicin—breast cancer	9.26e-06	0.000187	CcSEcCtD
Fluorouracil—Agranulocytosis—Doxorubicin—breast cancer	9.21e-06	0.000186	CcSEcCtD
Fluorouracil—Rash—Mitoxantrone—breast cancer	9.2e-06	0.000186	CcSEcCtD
Fluorouracil—Rash—Irinotecan—breast cancer	9.2e-06	0.000186	CcSEcCtD
Fluorouracil—Dermatitis—Mitoxantrone—breast cancer	9.2e-06	0.000185	CcSEcCtD
Fluorouracil—Dermatitis—Irinotecan—breast cancer	9.2e-06	0.000185	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Docetaxel—breast cancer	9.19e-06	0.000185	CcSEcCtD
Fluorouracil—Headache—Mitoxantrone—breast cancer	9.14e-06	0.000184	CcSEcCtD
Fluorouracil—Headache—Irinotecan—breast cancer	9.14e-06	0.000184	CcSEcCtD
Fluorouracil—Hypotension—Capecitabine—breast cancer	9.13e-06	0.000184	CcSEcCtD
Fluorouracil—Insomnia—Docetaxel—breast cancer	9.13e-06	0.000184	CcSEcCtD
Fluorouracil—Paraesthesia—Docetaxel—breast cancer	9.06e-06	0.000183	CcSEcCtD
Fluorouracil—Alopecia—Methotrexate—breast cancer	9.05e-06	0.000182	CcSEcCtD
Fluorouracil—Vomiting—Gemcitabine—breast cancer	9.04e-06	0.000182	CcSEcCtD
Fluorouracil—Dyspnoea—Docetaxel—breast cancer	9e-06	0.000181	CcSEcCtD
Fluorouracil—Somnolence—Docetaxel—breast cancer	8.97e-06	0.000181	CcSEcCtD
Fluorouracil—Rash—Gemcitabine—breast cancer	8.97e-06	0.000181	CcSEcCtD
Fluorouracil—Dermatitis—Gemcitabine—breast cancer	8.96e-06	0.000181	CcSEcCtD
Fluorouracil—Erythema—Methotrexate—breast cancer	8.91e-06	0.00018	CcSEcCtD
Fluorouracil—Haemoglobin—Doxorubicin—breast cancer	8.91e-06	0.00018	CcSEcCtD
Fluorouracil—Headache—Gemcitabine—breast cancer	8.91e-06	0.00018	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Capecitabine—breast cancer	8.9e-06	0.00018	CcSEcCtD
Fluorouracil—Rhinitis—Doxorubicin—breast cancer	8.89e-06	0.000179	CcSEcCtD
Fluorouracil—Dyspepsia—Docetaxel—breast cancer	8.88e-06	0.000179	CcSEcCtD
Fluorouracil—Haemorrhage—Doxorubicin—breast cancer	8.86e-06	0.000179	CcSEcCtD
Fluorouracil—Insomnia—Capecitabine—breast cancer	8.84e-06	0.000178	CcSEcCtD
Fluorouracil—Hypoaesthesia—Doxorubicin—breast cancer	8.82e-06	0.000178	CcSEcCtD
Fluorouracil—Pharyngitis—Doxorubicin—breast cancer	8.8e-06	0.000177	CcSEcCtD
Fluorouracil—Paraesthesia—Capecitabine—breast cancer	8.77e-06	0.000177	CcSEcCtD
Fluorouracil—Decreased appetite—Docetaxel—breast cancer	8.77e-06	0.000177	CcSEcCtD
Fluorouracil—Hypersensitivity—Paclitaxel—breast cancer	8.77e-06	0.000177	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Docetaxel—breast cancer	8.71e-06	0.000176	CcSEcCtD
Fluorouracil—Dyspnoea—Capecitabine—breast cancer	8.71e-06	0.000176	CcSEcCtD
Fluorouracil—Nausea—Mitoxantrone—breast cancer	8.67e-06	0.000175	CcSEcCtD
Fluorouracil—Nausea—Irinotecan—breast cancer	8.67e-06	0.000175	CcSEcCtD
Fluorouracil—Pain—Docetaxel—breast cancer	8.63e-06	0.000174	CcSEcCtD
Fluorouracil—Dyspepsia—Capecitabine—breast cancer	8.6e-06	0.000173	CcSEcCtD
Fluorouracil—Arrhythmia—Epirubicin—breast cancer	8.56e-06	0.000173	CcSEcCtD
Fluorouracil—Decreased appetite—Capecitabine—breast cancer	8.49e-06	0.000171	CcSEcCtD
Fluorouracil—Alopecia—Epirubicin—breast cancer	8.47e-06	0.000171	CcSEcCtD
Fluorouracil—Nausea—Gemcitabine—breast cancer	8.45e-06	0.00017	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Capecitabine—breast cancer	8.43e-06	0.00017	CcSEcCtD
Fluorouracil—Pruritus—Paclitaxel—breast cancer	8.42e-06	0.00017	CcSEcCtD
Fluorouracil—Vision blurred—Methotrexate—breast cancer	8.4e-06	0.000169	CcSEcCtD
Fluorouracil—Pain—Capecitabine—breast cancer	8.35e-06	0.000168	CcSEcCtD
Fluorouracil—Erythema—Epirubicin—breast cancer	8.34e-06	0.000168	CcSEcCtD
Fluorouracil—Feeling abnormal—Docetaxel—breast cancer	8.32e-06	0.000168	CcSEcCtD
Fluorouracil—Anaemia—Methotrexate—breast cancer	8.24e-06	0.000166	CcSEcCtD
Fluorouracil—Diarrhoea—Paclitaxel—breast cancer	8.15e-06	0.000164	CcSEcCtD
Fluorouracil—Feeling abnormal—Capecitabine—breast cancer	8.05e-06	0.000162	CcSEcCtD
Fluorouracil—Body temperature increased—Docetaxel—breast cancer	7.98e-06	0.000161	CcSEcCtD
Fluorouracil—Leukopenia—Methotrexate—breast cancer	7.98e-06	0.000161	CcSEcCtD
Fluorouracil—Arrhythmia—Doxorubicin—breast cancer	7.92e-06	0.00016	CcSEcCtD
Fluorouracil—Dizziness—Paclitaxel—breast cancer	7.87e-06	0.000159	CcSEcCtD
Fluorouracil—Vision blurred—Epirubicin—breast cancer	7.86e-06	0.000158	CcSEcCtD
Fluorouracil—Alopecia—Doxorubicin—breast cancer	7.83e-06	0.000158	CcSEcCtD
Fluorouracil—Urticaria—Capecitabine—breast cancer	7.76e-06	0.000157	CcSEcCtD
Fluorouracil—Body temperature increased—Capecitabine—breast cancer	7.72e-06	0.000156	CcSEcCtD
Fluorouracil—Convulsion—Methotrexate—breast cancer	7.72e-06	0.000156	CcSEcCtD
Fluorouracil—Erythema—Doxorubicin—breast cancer	7.72e-06	0.000156	CcSEcCtD
Fluorouracil—Anaemia—Epirubicin—breast cancer	7.71e-06	0.000155	CcSEcCtD
Fluorouracil—Chest pain—Methotrexate—breast cancer	7.59e-06	0.000153	CcSEcCtD
Fluorouracil—Myalgia—Methotrexate—breast cancer	7.59e-06	0.000153	CcSEcCtD
Fluorouracil—Vomiting—Paclitaxel—breast cancer	7.57e-06	0.000153	CcSEcCtD
Fluorouracil—Rash—Paclitaxel—breast cancer	7.51e-06	0.000151	CcSEcCtD
Fluorouracil—Dermatitis—Paclitaxel—breast cancer	7.5e-06	0.000151	CcSEcCtD
Fluorouracil—Discomfort—Methotrexate—breast cancer	7.5e-06	0.000151	CcSEcCtD
Fluorouracil—Leukopenia—Epirubicin—breast cancer	7.46e-06	0.000151	CcSEcCtD
Fluorouracil—Headache—Paclitaxel—breast cancer	7.46e-06	0.00015	CcSEcCtD
Fluorouracil—Hypersensitivity—Docetaxel—breast cancer	7.43e-06	0.00015	CcSEcCtD
Fluorouracil—Confusional state—Methotrexate—breast cancer	7.33e-06	0.000148	CcSEcCtD
Fluorouracil—Anaphylactic shock—Methotrexate—breast cancer	7.27e-06	0.000147	CcSEcCtD
Fluorouracil—Vision blurred—Doxorubicin—breast cancer	7.27e-06	0.000147	CcSEcCtD
Fluorouracil—Convulsion—Epirubicin—breast cancer	7.23e-06	0.000146	CcSEcCtD
Fluorouracil—Infection—Methotrexate—breast cancer	7.23e-06	0.000146	CcSEcCtD
Fluorouracil—Hypersensitivity—Capecitabine—breast cancer	7.2e-06	0.000145	CcSEcCtD
Fluorouracil—Pruritus—Docetaxel—breast cancer	7.14e-06	0.000144	CcSEcCtD
Fluorouracil—Nervous system disorder—Methotrexate—breast cancer	7.13e-06	0.000144	CcSEcCtD
Fluorouracil—Anaemia—Doxorubicin—breast cancer	7.13e-06	0.000144	CcSEcCtD
Fluorouracil—Thrombocytopenia—Methotrexate—breast cancer	7.12e-06	0.000144	CcSEcCtD
Fluorouracil—Chest pain—Epirubicin—breast cancer	7.1e-06	0.000143	CcSEcCtD
Fluorouracil—Myalgia—Epirubicin—breast cancer	7.1e-06	0.000143	CcSEcCtD
Fluorouracil—Nausea—Paclitaxel—breast cancer	7.07e-06	0.000143	CcSEcCtD
Fluorouracil—Discomfort—Epirubicin—breast cancer	7.01e-06	0.000141	CcSEcCtD
Fluorouracil—Anorexia—Methotrexate—breast cancer	6.93e-06	0.00014	CcSEcCtD
Fluorouracil—Pruritus—Capecitabine—breast cancer	6.91e-06	0.000139	CcSEcCtD
Fluorouracil—Leukopenia—Doxorubicin—breast cancer	6.91e-06	0.000139	CcSEcCtD
Fluorouracil—Diarrhoea—Docetaxel—breast cancer	6.9e-06	0.000139	CcSEcCtD
Fluorouracil—Confusional state—Epirubicin—breast cancer	6.86e-06	0.000138	CcSEcCtD
Fluorouracil—Anaphylactic shock—Epirubicin—breast cancer	6.81e-06	0.000137	CcSEcCtD
Fluorouracil—Oedema—Epirubicin—breast cancer	6.81e-06	0.000137	CcSEcCtD
Fluorouracil—Hypotension—Methotrexate—breast cancer	6.8e-06	0.000137	CcSEcCtD
Fluorouracil—Infection—Epirubicin—breast cancer	6.76e-06	0.000136	CcSEcCtD
Fluorouracil—Convulsion—Doxorubicin—breast cancer	6.69e-06	0.000135	CcSEcCtD
Fluorouracil—Diarrhoea—Capecitabine—breast cancer	6.68e-06	0.000135	CcSEcCtD
Fluorouracil—Nervous system disorder—Epirubicin—breast cancer	6.67e-06	0.000135	CcSEcCtD
Fluorouracil—Dizziness—Docetaxel—breast cancer	6.67e-06	0.000135	CcSEcCtD
Fluorouracil—Thrombocytopenia—Epirubicin—breast cancer	6.66e-06	0.000134	CcSEcCtD
Fluorouracil—Tachycardia—Epirubicin—breast cancer	6.64e-06	0.000134	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Methotrexate—breast cancer	6.63e-06	0.000134	CcSEcCtD
Fluorouracil—Insomnia—Methotrexate—breast cancer	6.58e-06	0.000133	CcSEcCtD
Fluorouracil—Chest pain—Doxorubicin—breast cancer	6.57e-06	0.000132	CcSEcCtD
Fluorouracil—Myalgia—Doxorubicin—breast cancer	6.57e-06	0.000132	CcSEcCtD
Fluorouracil—Paraesthesia—Methotrexate—breast cancer	6.53e-06	0.000132	CcSEcCtD
Fluorouracil—Discomfort—Doxorubicin—breast cancer	6.49e-06	0.000131	CcSEcCtD
Fluorouracil—Anorexia—Epirubicin—breast cancer	6.49e-06	0.000131	CcSEcCtD
Fluorouracil—Dyspnoea—Methotrexate—breast cancer	6.48e-06	0.000131	CcSEcCtD
Fluorouracil—Somnolence—Methotrexate—breast cancer	6.47e-06	0.00013	CcSEcCtD
Fluorouracil—Dizziness—Capecitabine—breast cancer	6.46e-06	0.00013	CcSEcCtD
Fluorouracil—Vomiting—Docetaxel—breast cancer	6.42e-06	0.000129	CcSEcCtD
Fluorouracil—Dyspepsia—Methotrexate—breast cancer	6.4e-06	0.000129	CcSEcCtD
Fluorouracil—Rash—Docetaxel—breast cancer	6.36e-06	0.000128	CcSEcCtD
Fluorouracil—Hypotension—Epirubicin—breast cancer	6.36e-06	0.000128	CcSEcCtD
Fluorouracil—Dermatitis—Docetaxel—breast cancer	6.36e-06	0.000128	CcSEcCtD
Fluorouracil—Confusional state—Doxorubicin—breast cancer	6.35e-06	0.000128	CcSEcCtD
Fluorouracil—Decreased appetite—Methotrexate—breast cancer	6.32e-06	0.000127	CcSEcCtD
Fluorouracil—Headache—Docetaxel—breast cancer	6.32e-06	0.000127	CcSEcCtD
Fluorouracil—Oedema—Doxorubicin—breast cancer	6.3e-06	0.000127	CcSEcCtD
Fluorouracil—Anaphylactic shock—Doxorubicin—breast cancer	6.3e-06	0.000127	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Methotrexate—breast cancer	6.28e-06	0.000127	CcSEcCtD
Fluorouracil—Infection—Doxorubicin—breast cancer	6.26e-06	0.000126	CcSEcCtD
Fluorouracil—Pain—Methotrexate—breast cancer	6.22e-06	0.000125	CcSEcCtD
Fluorouracil—Vomiting—Capecitabine—breast cancer	6.21e-06	0.000125	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Epirubicin—breast cancer	6.2e-06	0.000125	CcSEcCtD
Fluorouracil—Nervous system disorder—Doxorubicin—breast cancer	6.18e-06	0.000125	CcSEcCtD
Fluorouracil—Thrombocytopenia—Doxorubicin—breast cancer	6.17e-06	0.000124	CcSEcCtD
Fluorouracil—Rash—Capecitabine—breast cancer	6.16e-06	0.000124	CcSEcCtD
Fluorouracil—Insomnia—Epirubicin—breast cancer	6.16e-06	0.000124	CcSEcCtD
Fluorouracil—Dermatitis—Capecitabine—breast cancer	6.15e-06	0.000124	CcSEcCtD
Fluorouracil—Tachycardia—Doxorubicin—breast cancer	6.15e-06	0.000124	CcSEcCtD
Fluorouracil—Headache—Capecitabine—breast cancer	6.12e-06	0.000123	CcSEcCtD
Fluorouracil—Paraesthesia—Epirubicin—breast cancer	6.11e-06	0.000123	CcSEcCtD
Fluorouracil—Dyspnoea—Epirubicin—breast cancer	6.07e-06	0.000122	CcSEcCtD
Fluorouracil—Somnolence—Epirubicin—breast cancer	6.05e-06	0.000122	CcSEcCtD
Fluorouracil—Anorexia—Doxorubicin—breast cancer	6e-06	0.000121	CcSEcCtD
Fluorouracil—Nausea—Docetaxel—breast cancer	5.99e-06	0.000121	CcSEcCtD
Fluorouracil—Feeling abnormal—Methotrexate—breast cancer	5.99e-06	0.000121	CcSEcCtD
Fluorouracil—Dyspepsia—Epirubicin—breast cancer	5.99e-06	0.000121	CcSEcCtD
Fluorouracil—Decreased appetite—Epirubicin—breast cancer	5.92e-06	0.000119	CcSEcCtD
Fluorouracil—Hypotension—Doxorubicin—breast cancer	5.88e-06	0.000119	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Epirubicin—breast cancer	5.88e-06	0.000118	CcSEcCtD
Fluorouracil—Pain—Epirubicin—breast cancer	5.82e-06	0.000117	CcSEcCtD
Fluorouracil—Nausea—Capecitabine—breast cancer	5.8e-06	0.000117	CcSEcCtD
Fluorouracil—Urticaria—Methotrexate—breast cancer	5.78e-06	0.000117	CcSEcCtD
Fluorouracil—Body temperature increased—Methotrexate—breast cancer	5.75e-06	0.000116	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Doxorubicin—breast cancer	5.74e-06	0.000116	CcSEcCtD
Fluorouracil—Insomnia—Doxorubicin—breast cancer	5.7e-06	0.000115	CcSEcCtD
Fluorouracil—Paraesthesia—Doxorubicin—breast cancer	5.65e-06	0.000114	CcSEcCtD
Fluorouracil—Dyspnoea—Doxorubicin—breast cancer	5.61e-06	0.000113	CcSEcCtD
Fluorouracil—Feeling abnormal—Epirubicin—breast cancer	5.61e-06	0.000113	CcSEcCtD
Fluorouracil—Somnolence—Doxorubicin—breast cancer	5.6e-06	0.000113	CcSEcCtD
Fluorouracil—Dyspepsia—Doxorubicin—breast cancer	5.54e-06	0.000112	CcSEcCtD
Fluorouracil—Decreased appetite—Doxorubicin—breast cancer	5.47e-06	0.00011	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Doxorubicin—breast cancer	5.44e-06	0.00011	CcSEcCtD
Fluorouracil—Urticaria—Epirubicin—breast cancer	5.41e-06	0.000109	CcSEcCtD
Fluorouracil—Pain—Doxorubicin—breast cancer	5.39e-06	0.000109	CcSEcCtD
Fluorouracil—Body temperature increased—Epirubicin—breast cancer	5.38e-06	0.000109	CcSEcCtD
Fluorouracil—Hypersensitivity—Methotrexate—breast cancer	5.36e-06	0.000108	CcSEcCtD
Fluorouracil—Feeling abnormal—Doxorubicin—breast cancer	5.19e-06	0.000105	CcSEcCtD
Fluorouracil—Pruritus—Methotrexate—breast cancer	5.15e-06	0.000104	CcSEcCtD
Fluorouracil—Hypersensitivity—Epirubicin—breast cancer	5.01e-06	0.000101	CcSEcCtD
Fluorouracil—Urticaria—Doxorubicin—breast cancer	5e-06	0.000101	CcSEcCtD
Fluorouracil—Body temperature increased—Doxorubicin—breast cancer	4.98e-06	0.0001	CcSEcCtD
Fluorouracil—Diarrhoea—Methotrexate—breast cancer	4.98e-06	0.0001	CcSEcCtD
Fluorouracil—Pruritus—Epirubicin—breast cancer	4.82e-06	9.71e-05	CcSEcCtD
Fluorouracil—Dizziness—Methotrexate—breast cancer	4.81e-06	9.7e-05	CcSEcCtD
Fluorouracil—Diarrhoea—Epirubicin—breast cancer	4.66e-06	9.39e-05	CcSEcCtD
Fluorouracil—Hypersensitivity—Doxorubicin—breast cancer	4.64e-06	9.36e-05	CcSEcCtD
Fluorouracil—Vomiting—Methotrexate—breast cancer	4.62e-06	9.33e-05	CcSEcCtD
Fluorouracil—Rash—Methotrexate—breast cancer	4.59e-06	9.25e-05	CcSEcCtD
Fluorouracil—Dermatitis—Methotrexate—breast cancer	4.58e-06	9.24e-05	CcSEcCtD
Fluorouracil—Headache—Methotrexate—breast cancer	4.56e-06	9.19e-05	CcSEcCtD
Fluorouracil—Dizziness—Epirubicin—breast cancer	4.5e-06	9.08e-05	CcSEcCtD
Fluorouracil—Pruritus—Doxorubicin—breast cancer	4.46e-06	8.99e-05	CcSEcCtD
Fluorouracil—Vomiting—Epirubicin—breast cancer	4.33e-06	8.73e-05	CcSEcCtD
Fluorouracil—Nausea—Methotrexate—breast cancer	4.32e-06	8.71e-05	CcSEcCtD
Fluorouracil—Diarrhoea—Doxorubicin—breast cancer	4.31e-06	8.69e-05	CcSEcCtD
Fluorouracil—Rash—Epirubicin—breast cancer	4.29e-06	8.65e-05	CcSEcCtD
Fluorouracil—Dermatitis—Epirubicin—breast cancer	4.29e-06	8.65e-05	CcSEcCtD
Fluorouracil—Headache—Epirubicin—breast cancer	4.26e-06	8.6e-05	CcSEcCtD
Fluorouracil—Dizziness—Doxorubicin—breast cancer	4.16e-06	8.4e-05	CcSEcCtD
Fluorouracil—Nausea—Epirubicin—breast cancer	4.04e-06	8.15e-05	CcSEcCtD
Fluorouracil—Vomiting—Doxorubicin—breast cancer	4e-06	8.07e-05	CcSEcCtD
Fluorouracil—Rash—Doxorubicin—breast cancer	3.97e-06	8.01e-05	CcSEcCtD
Fluorouracil—Dermatitis—Doxorubicin—breast cancer	3.97e-06	8e-05	CcSEcCtD
Fluorouracil—Headache—Doxorubicin—breast cancer	3.95e-06	7.96e-05	CcSEcCtD
Fluorouracil—Nausea—Doxorubicin—breast cancer	3.74e-06	7.54e-05	CcSEcCtD
Fluorouracil—ABCG2—Metabolism—MTHFR—breast cancer	5.2e-07	1.18e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ALDOA—breast cancer	5.19e-07	1.18e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—NCOA2—breast cancer	5.17e-07	1.18e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NAT2—breast cancer	5.14e-07	1.17e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NCOA2—breast cancer	5.14e-07	1.17e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GPX1—breast cancer	5.12e-07	1.16e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CB—breast cancer	5.1e-07	1.16e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—HRAS—breast cancer	5.1e-07	1.16e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PTEN—breast cancer	5.07e-07	1.15e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CYP1A1—breast cancer	5.07e-07	1.15e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NCOA3—breast cancer	5.04e-07	1.15e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ERCC2—breast cancer	5.03e-07	1.14e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—FASN—breast cancer	5.02e-07	1.14e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SLC2A2—breast cancer	5.01e-07	1.14e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—BCHE—breast cancer	4.99e-07	1.14e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—FASN—breast cancer	4.99e-07	1.13e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—BCHE—breast cancer	4.97e-07	1.13e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.96e-07	1.13e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SLC5A5—breast cancer	4.93e-07	1.12e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—AKT1—breast cancer	4.92e-07	1.12e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ABCG2—breast cancer	4.91e-07	1.12e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CPT1A—breast cancer	4.91e-07	1.12e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—MTR—breast cancer	4.91e-07	1.12e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SLC5A5—breast cancer	4.91e-07	1.12e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—IL6—breast cancer	4.88e-07	1.11e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CB—breast cancer	4.86e-07	1.1e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTGS2—breast cancer	4.81e-07	1.09e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—HPGDS—breast cancer	4.81e-07	1.09e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CAV1—breast cancer	4.8e-07	1.09e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PIK3CA—breast cancer	4.79e-07	1.09e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—HBA1—breast cancer	4.78e-07	1.09e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SLC2A1—breast cancer	4.76e-07	1.08e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—NQO1—breast cancer	4.76e-07	1.08e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NQO1—breast cancer	4.74e-07	1.08e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SLC2A1—breast cancer	4.74e-07	1.08e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—MTHFR—breast cancer	4.72e-07	1.07e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—IL2—breast cancer	4.68e-07	1.06e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTT1—breast cancer	4.67e-07	1.06e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ACHE—breast cancer	4.67e-07	1.06e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.67e-07	1.06e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	4.65e-07	1.06e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP3A4—breast cancer	4.65e-07	1.06e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.64e-07	1.05e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.62e-07	1.05e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP3A4—breast cancer	4.62e-07	1.05e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PIK3CA—breast cancer	4.61e-07	1.05e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.6e-07	1.05e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP1B1—breast cancer	4.57e-07	1.04e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP1B1—breast cancer	4.54e-07	1.03e-05	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	4.52e-07	1.03e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—MED12—breast cancer	4.51e-07	1.03e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—DPYD—breast cancer	4.51e-07	1.03e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—AKT1—breast cancer	4.5e-07	1.02e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—HSP90AA1—breast cancer	4.48e-07	1.02e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—HSP90AA1—breast cancer	4.45e-07	1.01e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ALDOA—breast cancer	4.44e-07	1.01e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—HRAS—breast cancer	4.44e-07	1.01e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP17A1—breast cancer	4.42e-07	1e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ENO1—breast cancer	4.37e-07	9.94e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTGS1—breast cancer	4.37e-07	9.94e-06	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CG—breast cancer	4.37e-07	9.94e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CAV1—breast cancer	4.36e-07	9.91e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—NCOA1—breast cancer	4.36e-07	9.91e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.36e-07	9.91e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NCOA1—breast cancer	4.33e-07	9.85e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NCOA3—breast cancer	4.31e-07	9.8e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.3e-07	9.78e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—STK11—breast cancer	4.29e-07	9.77e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP19A1—breast cancer	4.29e-07	9.77e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP2D6—breast cancer	4.29e-07	9.75e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SLC2A2—breast cancer	4.28e-07	9.73e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—STK11—breast cancer	4.27e-07	9.71e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP19A1—breast cancer	4.27e-07	9.71e-06	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—IL6—breast cancer	4.25e-07	9.65e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.23e-07	9.63e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NCOA2—breast cancer	4.21e-07	9.57e-06	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTEN—breast cancer	4.2e-07	9.54e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—MTR—breast cancer	4.19e-07	9.53e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CPT1A—breast cancer	4.19e-07	9.53e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ABCG2—breast cancer	4.19e-07	9.53e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—HPGDS—breast cancer	4.11e-07	9.35e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—HBA1—breast cancer	4.09e-07	9.29e-06	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—SRC—breast cancer	4.08e-07	9.29e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—FASN—breast cancer	4.08e-07	9.28e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—BCHE—breast cancer	4.06e-07	9.24e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.03e-07	9.17e-06	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CA—breast cancer	4.02e-07	9.13e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SLC5A5—breast cancer	4.01e-07	9.13e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.01e-07	9.12e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—COMT—breast cancer	3.99e-07	9.08e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTT1—breast cancer	3.99e-07	9.07e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ACHE—breast cancer	3.99e-07	9.07e-06	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—VEGFA—breast cancer	3.98e-07	9.04e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTP1—breast cancer	3.97e-07	9.04e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—COMT—breast cancer	3.97e-07	9.03e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CG—breast cancer	3.97e-07	9.03e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTP1—breast cancer	3.95e-07	8.98e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—HMOX1—breast cancer	3.92e-07	8.91e-06	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—AKT1—breast cancer	3.92e-07	8.91e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ITPR1—breast cancer	3.91e-07	8.89e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—HMOX1—breast cancer	3.9e-07	8.86e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ITPR1—breast cancer	3.89e-07	8.84e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NQO1—breast cancer	3.88e-07	8.82e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SLC2A1—breast cancer	3.88e-07	8.82e-06	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CD—breast cancer	3.84e-07	8.73e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.8e-07	8.63e-06	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ALB—breast cancer	3.79e-07	8.62e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP3A4—breast cancer	3.78e-07	8.6e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP17A1—breast cancer	3.77e-07	8.58e-06	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—AKT1—breast cancer	3.77e-07	8.57e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.76e-07	8.56e-06	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—MAPK3—breast cancer	3.76e-07	8.55e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ABCB1—breast cancer	3.76e-07	8.55e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ABCB1—breast cancer	3.74e-07	8.51e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ENO1—breast cancer	3.74e-07	8.5e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTGS1—breast cancer	3.74e-07	8.5e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.72e-07	8.46e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP1B1—breast cancer	3.72e-07	8.45e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—TYMS—breast cancer	3.69e-07	8.4e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.67e-07	8.36e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—TYMS—breast cancer	3.67e-07	8.35e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP2D6—breast cancer	3.66e-07	8.33e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PLA2G4A—breast cancer	3.65e-07	8.3e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—NCOR1—breast cancer	3.65e-07	8.3e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTM1—breast cancer	3.65e-07	8.3e-06	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TGFB1—breast cancer	3.65e-07	8.3e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—HSP90AA1—breast cancer	3.65e-07	8.29e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTM1—breast cancer	3.63e-07	8.26e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NCOR1—breast cancer	3.63e-07	8.26e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PLA2G4A—breast cancer	3.63e-07	8.26e-06	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—NOS3—breast cancer	3.63e-07	8.25e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NCOA2—breast cancer	3.6e-07	8.18e-06	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CA—breast cancer	3.58e-07	8.13e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NCOA1—breast cancer	3.55e-07	8.06e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GPX1—breast cancer	3.5e-07	7.95e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—STK11—breast cancer	3.5e-07	7.95e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP19A1—breast cancer	3.5e-07	7.95e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CD—breast cancer	3.49e-07	7.94e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—FASN—breast cancer	3.49e-07	7.93e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GPX1—breast cancer	3.48e-07	7.91e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—BCHE—breast cancer	3.47e-07	7.9e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP1A1—breast cancer	3.46e-07	7.87e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ALB—breast cancer	3.44e-07	7.83e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP1A1—breast cancer	3.44e-07	7.83e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ERCC2—breast cancer	3.43e-07	7.81e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SLC5A5—breast cancer	3.43e-07	7.8e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ERCC2—breast cancer	3.41e-07	7.76e-06	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—KRAS—breast cancer	3.38e-07	7.69e-06	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CB—breast cancer	3.35e-07	7.61e-06	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTGS2—breast cancer	3.32e-07	7.54e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SLC2A1—breast cancer	3.31e-07	7.54e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NQO1—breast cancer	3.31e-07	7.54e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—NOS3—breast cancer	3.3e-07	7.49e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.28e-07	7.46e-06	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—AKT1—breast cancer	3.28e-07	7.46e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—COMT—breast cancer	3.25e-07	7.39e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.24e-07	7.38e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTP1—breast cancer	3.23e-07	7.35e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP3A4—breast cancer	3.23e-07	7.35e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—MTHFR—breast cancer	3.23e-07	7.34e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.21e-07	7.31e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—MTHFR—breast cancer	3.21e-07	7.3e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—HMOX1—breast cancer	3.19e-07	7.25e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ITPR1—breast cancer	3.18e-07	7.24e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP1B1—breast cancer	3.18e-07	7.22e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—HSP90AA1—breast cancer	3.12e-07	7.08e-06	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CA—breast cancer	3.11e-07	7.06e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ABCB1—breast cancer	3.06e-07	6.96e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CB—breast cancer	3.04e-07	6.92e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NCOA1—breast cancer	3.03e-07	6.89e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTGS2—breast cancer	3.01e-07	6.85e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—TYMS—breast cancer	3.01e-07	6.84e-06	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TP53—breast cancer	3e-07	6.83e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP19A1—breast cancer	2.99e-07	6.79e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—STK11—breast cancer	2.99e-07	6.79e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CAV1—breast cancer	2.98e-07	6.77e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.97e-07	6.76e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NCOR1—breast cancer	2.97e-07	6.76e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTM1—breast cancer	2.97e-07	6.76e-06	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CA—breast cancer	2.96e-07	6.73e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CAV1—breast cancer	2.96e-07	6.73e-06	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—AKT1—breast cancer	2.92e-07	6.64e-06	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTEN—breast cancer	2.89e-07	6.58e-06	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—HRAS—breast cancer	2.87e-07	6.53e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GPX1—breast cancer	2.85e-07	6.47e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.84e-07	6.47e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.83e-07	6.43e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP1A1—breast cancer	2.82e-07	6.41e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.8e-07	6.38e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ERCC2—breast cancer	2.79e-07	6.35e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—COMT—breast cancer	2.78e-07	6.31e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTP1—breast cancer	2.76e-07	6.28e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—HMOX1—breast cancer	2.73e-07	6.2e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ITPR1—breast cancer	2.72e-07	6.18e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CG—breast cancer	2.71e-07	6.17e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CG—breast cancer	2.7e-07	6.13e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTEN—breast cancer	2.63e-07	5.98e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—MTHFR—breast cancer	2.63e-07	5.97e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ABCB1—breast cancer	2.62e-07	5.95e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—TYMS—breast cancer	2.57e-07	5.84e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PLA2G4A—breast cancer	2.54e-07	5.78e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NCOR1—breast cancer	2.54e-07	5.78e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTM1—breast cancer	2.54e-07	5.78e-06	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—AKT1—breast cancer	2.54e-07	5.77e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GPX1—breast cancer	2.43e-07	5.53e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CAV1—breast cancer	2.42e-07	5.51e-06	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AKT1—breast cancer	2.42e-07	5.5e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP1A1—breast cancer	2.41e-07	5.47e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ERCC2—breast cancer	2.39e-07	5.43e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CD—breast cancer	2.38e-07	5.42e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CD—breast cancer	2.37e-07	5.39e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ALB—breast cancer	2.35e-07	5.35e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.31e-07	5.26e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—NOS3—breast cancer	2.25e-07	5.12e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—MTHFR—breast cancer	2.24e-07	5.1e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NOS3—breast cancer	2.24e-07	5.09e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CG—breast cancer	2.21e-07	5.02e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CB—breast cancer	2.08e-07	4.72e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CAV1—breast cancer	2.07e-07	4.71e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CB—breast cancer	2.07e-07	4.7e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTGS2—breast cancer	2.06e-07	4.68e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTGS2—breast cancer	2.05e-07	4.65e-06	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CA—breast cancer	2.04e-07	4.64e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.98e-07	4.5e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CD—breast cancer	1.94e-07	4.41e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ALB—breast cancer	1.92e-07	4.36e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CG—breast cancer	1.89e-07	4.29e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CA—breast cancer	1.85e-07	4.22e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NOS3—breast cancer	1.83e-07	4.17e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTEN—breast cancer	1.8e-07	4.08e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTEN—breast cancer	1.79e-07	4.06e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CB—breast cancer	1.69e-07	3.85e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTGS2—breast cancer	1.68e-07	3.81e-06	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AKT1—breast cancer	1.67e-07	3.79e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CD—breast cancer	1.66e-07	3.77e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ALB—breast cancer	1.64e-07	3.72e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NOS3—breast cancer	1.57e-07	3.56e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AKT1—breast cancer	1.51e-07	3.44e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTEN—breast cancer	1.46e-07	3.32e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CB—breast cancer	1.44e-07	3.29e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTGS2—breast cancer	1.43e-07	3.26e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CA—breast cancer	1.27e-07	2.88e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CA—breast cancer	1.26e-07	2.86e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTEN—breast cancer	1.25e-07	2.84e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AKT1—breast cancer	1.03e-07	2.35e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CA—breast cancer	1.03e-07	2.34e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AKT1—breast cancer	1.03e-07	2.34e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CA—breast cancer	8.81e-08	2e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AKT1—breast cancer	8.42e-08	1.91e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AKT1—breast cancer	7.2e-08	1.64e-06	CbGpPWpGaD
